Premium
Enhancement of coenzyme binding by a single point mutation at the coenzyme binding domain of E. coli lactaldehyde dehydrogenase
Author(s) -
RodríguezZavala José Salud
Publication year - 2008
Publication title -
protein science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.353
H-Index - 175
eISSN - 1469-896X
pISSN - 0961-8368
DOI - 10.1110/ps.073277108
Subject(s) - nad+ kinase , cofactor , dehydrogenase , enzyme , biochemistry , chemistry , stereochemistry , coenzyme a , mutant , reductase , gene
Abstract Phenylacetaldehyde dehydrogenase (PAD) and lactaldehyde dehydrogenase (ALD) share some structural and kinetic properties. One difference is that PAD can use NAD + and NADP + , whereas ALD only uses NAD + . An acidic residue has been involved in the exclusion of NADP + from the active site in pyridine nucleotide‐dependent dehydrogenases. However, other factors may participate in NADP + exclusion. In the present work, analysis of the sequence of the region involved in coenzyme binding showed that residue F180 of ALD might participate in coenzyme specificity. Interestingly, F180T mutation rendered an enzyme (ALD‐F180T) with the ability to use NADP + . This enzyme showed an activity of 0.87 μmol/(min * mg) and K m for NADP + of 78 μM. Furthermore, ALD‐F180T exhibited a 16‐fold increase in the V m / K m ratio with NAD + as the coenzyme, from 12.8 to 211. This increase in catalytic efficiency was due to a diminution in K m for NAD + from 47 to 7 μM and a higher V m from 0.51 to 1.48 μmol/(min * mg). In addition, an increased K d for NADH from 175 (wild‐type) to 460 μM (mutant) indicates a faster product release and possibly a change in the rate‐limiting step. For wild‐type ALD it is described that the rate‐limiting step is shared between deacylation and coenzyme dissociation. In contrast, in the present report the rate‐limiting step in ALD‐F180T was determined to be exclusively deacylation. In conclusion, residue F180 participates in the exclusion of NADP + from the coenzyme binding site and disturbs the binding of NAD + .